Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.14 -0.01 (-0.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Long-Term Debt Repayments (2023 - 2025)

Updated

Oramed Pharmaceuticals (ORMP) reported Long-Term Debt Repayments of $69.2 million for FY2025, up 39.7% from $49.55 million in FY2024.

Analysis

Oramed Pharmaceuticals (ORMP) Long-Term Debt Repayments (2023 - 2025) Analysis & Trends

  • According to Business Quant data, Long-Term Debt Repayments came in at $49.55 million in FY2024 (-0.9%) and $50 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Oramed Pharmaceuticals 169.50 Mn -165.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 69.20 Mn
Jun 30, 2024 30.55 Mn
Mar 31, 2024 19.00 Mn
Dec 31, 2023 25.00 Mn
API Access

Oramed Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ORMP&period=max&api_key=YOUR_API_KEY